Adicet Bio Clears Debts with Banc of California

Adicet Bio ( (ACET) ) has issued an announcement.

Adicet Therapeutics, Inc., a subsidiary of Adicet Bio, Inc., finalized a payoff letter with Banc of California to clear all outstanding debts and terminate obligations under a previous loan agreement from 2020. The company paid around $10,000 without incurring any termination penalties and set up cash collateral accounts to secure additional services from the bank.

For detailed information about ACET stock, go to TipRanks’ Stock Analysis page.